Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | 5-Bromopyrimidine | HCID 78344 | — |
| Reactant | HCID 69961490 | HCID 69961490 | — |
| Catalyst | Tri-o-tolylphosphine | HCID 80271 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 9800722 | HCID 9800722 | — |
Reaction Steps
To a stirred solution of 2-[(S)-1-phenylethylamino]-4-[5-(tributylstannyl)-benzimidazol-1-yl]pyrimidine (27.7 mg) in THF (3 mL) was added 5-bromopyrimidine (22 mg), Pd2DBA3 (0.26 mg) and tri-o-tolylphosphine (0.47 mg). The mixture was heated and maintained at reflux for 2 h. Thin layer chromatographic analysis indicated there was mostly starting material present. DMF (3 mL) was added and the THF was removed under a stream of nitrogen. Tetrakis(triphenylphosphine)palladium(0) (1 mg) was added and the mixture was heated under nitrogen and maintained at 100° C. overnight. The mixture was then cooled and poured into 100 mL of 3:1 ether/ethyl acetate and washed 2× with water and then brine. The organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The product was purified by silica gel chromatography eluting with methanol in dichloromethane to give 11.3 mg of the title compound. Mass spectrum (ESI): 394.2 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06498165B1 |
|---|
| Source dataset | uspto-grants-2002_12 |
|---|
| ORD ID | ord-9562e4fc289a4cf28171bad84f814b80 |
|---|
| Source note | uspto-grants-2002_12 |
|---|